Navigation Links
Davis's Drug Guide, 10th edition

ProductsDavis's Drug Guide, 10th edition
Company Unbound Medicine, Inc.
Item Davis's Drug Guide, 10th edition
Features 
  • More than 1700 monographs
  • Almost 5000 trade and generic drugs
  • The most common herbal and natural products
  • 16 appendices with dose calculations, lab values, and more
  • 5 new indexes
  • Bookmark tool for quick return to critical information
  • Extensive cross-linking between drugs
  • Monographs include:Indications, Action, Pharmacokinetics, Contraindications/Precautions, Adverse Reactions/Side Effects, Interactions, Route/Dosage, Availability, Assessment, Potential Nursing Diagnoses, Implementation, Patient/Family Teaching, Evaluation
  • IV information with dose; dilution; syringe/Y-site/additive/solution compatibility and incompatibility; rate; clinical precautions; direct IV; intermittent infusion; continuous infusion; life-span considerations; IV compatibility and incompatibility
  • Regular updates for 12 months on the web or downloaded to your PDA when you sync
  • Color, high resolution, and landscape mode support
  • Secure digital (SD)card/memory stick support
  • Wireless access from any internet-enabled device--Palm OS, Pocket PC, Treo Smartphone, or BlackBerry
  • Navigation with an interface customized for your device
Description Davis's Drug Guide 10th edition has been revised throughout! Updates include 200 new drug monographs and 16 appendicies. Additional indexes and a new Bookmark tool help you retrieve the answers you need. Includes PDA, Web, and Wireless versions for one price.
Info Unbound Medicine, Inc.
Customer Service: (610) 627-9090
Web site: http://www.unboundmedicine.com/

Related medicine products :

1. Daviss Drug Guide for Nurses, 9th Edition for PDA
2. Daviss Drug Guide for Nurses
3. Daviss Drug Guide for Nurses with Integrated Calculators
4. Pinn-ACL Femoral Guide, right
5. Fiberoptic Light Guide, snap-on
6. Fiberoptic Light Guide, clip-on
7. High Transmission Autoclavable Fiberoptic Light Guide, snap-on
8. High Transmission Autoclavable Fiberoptic Light Guide, with 45 angled instrument fitting, snap-on
9. Tabers Cyclopedic Medical Dictionary 20th edition
Charmant's Pure Titanium Collection is the world's most extensive collection of titanium frames, consisting of 100% pure titanium and beta-titanium frames with ultra-lightweight strength, hypoallerge
The license agreement between Brook Brothers and Luxottica Group dates back to 1993. Characterized by lightweight materials and a slender line, the Brooks Brothers collections reflect the unique feat
The new Chanel optical collection, inspired by the codes of elegance dear to Mademoiselle's heart, from the interlinked double C to the quilted effect. Combining the purity of black with the sparkle
...sh restatement of everything thats creative and so...he creations include eighteen ladies models and fo...The style icons of the Florentine brand reassert t...s, striking details and prestige materials.,The Wo...
Medicine Products:
(Date:12/3/2008)...ffering free shipping to the end of the year. , ...- For the remainder of the year standard shipping ...e , to UK mainland addresses, excluding the highla...g the special voucher code SHIP4FREE on the Hyperd...tson says "Hyperdrug intends to give practica...
(Date:12/3/2008)... benchmark data providing information by disease s...ies , , SAN FRANCISCO, Dec. 3 /PRNewswire-U... for and effectiveness of their health and product...ed Benefits Institute (IBI) announced today the av... does IBI,s benchmarking offer the ability to acce...
(Date:12/3/2008)... cities in Tennessee have adopted,New Jersey,s un...C) it was,learned this week. An article in the C...at the cities of Athens and Englewood in the Volun...Jersey program through their health plan.,(The ar...f ) , The Mayors Wellness Campaign is an i...
(Date:12/3/2008)...ellus Specialties Inc., a leading specialty chemic...5-20% effective January 1, 2009 for 2-vinylpyridin... price increase is necessary to continue the compa...ide better supply chain logistics to its global cu...Inc. , , Vertellus is a specialty chemica...
Breaking Medicine News(10 mins):Health News:Beating the Credit Crunch with Hyperdrug.co.uk 2Health News:Integrated Benefits Institute Announces Availability of 2007 IBI Benchmarking Data for Employers to Evaluate Effectiveness of their Health and Productivity Programs 2Health News:New Jersey's 'Mayors Wellness Campaign' Goes National! 2
...of US army Gale Pollock was inspired to become a n...der brother after he was wounded in Vietnam. Thirt... Corps. // "I decided to join the army when I was...was injured in Vietnam and the army medical depart...
...tion was found at the St. Michael's and Toronto Ge...splant paired exchange occurred. The scenario was... dying //of kidney disease and the other unable to... because they weren't a compatible blood type. T...
...e University of Melbourne and La Trobe University ...t of fibre in grains such as wheat and barley. Wit... the Aussie researchers fell that this discovery w...content of foods. The genes are important in the ...
... to win and lose; money; of course but a new repor...r health. The reason is attributed to long hours a... state of casino working conditions by the GMB uni...repares to bid for a licence to operate a Las Vega...
Other Medicine News:Health News:Joining The Military 'My Best Move' - US Army Nursing Chief 2Health News:Innovative solution to help reduce the waiting times for kidney transplants 2Health News:Gamble for money, but casino workers gamble with their health! 2
(Date:12/3/2008)...lleviates long-term anemia and organ damage in mic..., MEMPHIS, Tenn., Dec. 3 /PRNewswire-USNewswire... gene into mouse blood cells, scientists at St. Ju...ckle cell disease pathology. In their studies, the...sentially no difference from normal mice. Although...
(Date:12/3/2008)... 3 The Leukemia & Lymphoma Soc...ginning of a new clinical trial of ISF35, a cancer...ego (UCSD). , , LLS is collaborating on ...elopment and approval of a novel approach aimed at.../or 17p deleted chronic lymphocytic leukemia (CLL)...
(Date:12/3/2008)...3 Wyeth Pharmaceuticals,...day that it has submitted a,marketing authorizati...ncy,(EMEA) for approval to market its investigati...V13) for infants and young children. Wyeth is see...ccal disease (PD) caused by the 13,serotypes incl...
(Date:12/3/2008)...Newswire/ -- Isogen, a contract development and,m...ounced it has retained a,strategic financial part...l,biopharma demand for Isogen,s services. , ...st round series of capital,investment and the ope... to,deliver on the previously unmet process, faci...
Breaking Medicine Technology:Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 2Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 3The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 2The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 3Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 2Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 3Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 4Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 5Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 2Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 3The Michigan Life Sciences Pipeline Adds More Resources On Its Website 7153 1The Michigan Life Sciences Pipeline Adds More Resources On Its Website 7153 2Clinical Trials Bootcamp Announces Inaugural Meeting 2838 1China Bio Energy Holdings Group Reports Second Quarter 2008 Financial Results 7148 1China Bio Energy Holdings Group Reports Second Quarter 2008 Financial Results 7148 2China Bio Energy Holdings Group Reports Second Quarter 2008 Financial Results 7148 3China Bio Energy Holdings Group Reports Second Quarter 2008 Financial Results 7148 4China Bio Energy Holdings Group Reports Second Quarter 2008 Financial Results 7148 5China Bio Energy Holdings Group Reports Second Quarter 2008 Financial Results 7148 6China Bio Energy Holdings Group Reports Second Quarter 2008 Financial Results 7148 7febit and TGen Collaborate to Study New DNA Capture Method 2837 1febit and TGen Collaborate to Study New DNA Capture Method 2837 2febit and TGen Collaborate to Study New DNA Capture Method 2837 3
...bstantial Response Rate,in Two Clinical Trials , C...udy of Oral,Azacitidine , Exelixis Reports Compreh...ts Integrated Data From Phase II Clinical Trials,o... in Hematologic Malignancies and,Advanced Solid Tu...osing Schedules in,MDS and in Combination with Val...
...-,Phytopharm plc (LSE: PYM) ("Phytopharm" or the "...g that Cogane(tm) reverses the,changes in the area...s data will be presented by Dr Jonathan Brotchie, ...s disease at ,The,11th International Congress of P...in Istanbul, Turkey and published in The Movement,...
Other Medicine Technology:Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 2Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 3Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 4Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 5Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 6Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 7Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 8Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 9Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 10Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 11Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 12Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 13Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 14Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 15Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 16Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 17Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 18Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 19Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 20Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 21Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 22Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 23Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 24Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 25Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 26Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 27Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 28Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 29Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 2Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 3Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 4Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 5